The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear

This activity covers 4 main topics: 1) The current standard of care for management of stage III non-small cell lung cancer, 2) Palliation of common issues such as hemoptysis, airway obstruction, and chest pain.

This session will review the key takeaways from the 2023 Multidisciplinary Thoracic Cancers Symposium.

Prognosis, therapeutic choices, end of life care are three key themes for patients with lung cancer.

Advancements in the diagnosis and treatment of thoracic cancers have improved survival rates, making survivorship issues such as fertility and sexual wellness a priority.

The management of stage III NSCLC is controversial and rapidly evolving, to the point that practitioners have difficulty processing and understanding the fast moving changes in the standard of care and communications among multidisciplinary teams is challenging given the uneven knowledge levels.

The role of multidisciplinary care for small cell lung cancer has never been more important. Novel insights into subclassification of small cell lung cancer may unlock novel therapies that may be effective for each subtype.

Thymic malignancies and mesothelioma are rare cancers that require complex multidisciplinary management.

There are many ongoing advances in patient safety in the context of radiation therapy delivery, clinical research on treatment options, and advanced techniques in radiotherapy delivery. Failure to stay informed leads to lower quality of care by practicing clinicians.